Ulrike Lange

Dr. Ulrike Lange


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 February 2020 in Seminars in Immunopathology
Verified
Journal Article
Open access
PDF file
ULUlrike Lange
Ulrike Lange
RVRoxane Verdikt
Roxane Verdikt
AAAmina Ait-Ammar
Amina Ait-Ammar
CLCarine Van Lint
Carine Van Lint
Human immunodeficiency virus 1 (HIV-1) replicates through the integration of its viral DNA into the genome of human immune target cells. Chronically infected individuals thus carry a genomic burden of virus-derived sequences that persists through antiretroviral therapy. This burden consists of a small fraction of intact, but transcriptionally silenced, i.e. latent, viral genomes and a dominant fraction of defective sequences. Remarkably, all viral-derived sequences are subject to interaction with host cellular physiology at various levels. In this review, we focus on epigenetic aspects of this interaction. We provide a comprehensive overview of how epigenetic mechanisms contribute to establishment and maintenance of HIV-1 gene repression during latency. We furthermore summarize findings indicating that HIV-1 infection leads to changes in the epigenome of target and bystander immune cells. Finally, we discuss how an improved understanding of epigenetic features and mechanisms involved in HIV-1 infection could be exploited for clinical use.

1 April 2018 in Virus Research
Verified
Journal Article
Closed access
ULUlrike Lange
Ulrike Lange
JBJulia K. Bialek
Julia K. Bialek
TWThomas Walther
Thomas Walther
JHJoachim Hauber
Joachim Hauber

1 February 2021 in Virus Research
Verified
Journal Article
Closed access
MHMartin V. Hamann
Martin V. Hamann
PEPhilipp Ehmele
Philipp Ehmele
RVRoxane Verdikt
Roxane Verdikt
JBJulia K. Bialek-Waldmann
Julia K. Bialek-Waldmann
SVSanamjeet Virdi
Sanamjeet Virdi
ULUlrike Lange
Ulrike Lange

14 November 2018 in Journal of Visualized Experiments
Verified
Journal Article
Closed access
PDF file
JBJulia K. Bialek
Julia K. Bialek
TWThomas Walther
Thomas Walther
JHJoachim Hauber
Joachim Hauber
ULUlrike Lange
Ulrike Lange
Human immunodeficiency virus (HIV) integrates its proviral DNA non-randomly into the host cell genome at recurrent sites and genomic hotspots. Here we present a detailed protocol for the generation of novel in vitro models for HIV infection with chosen genomic integration sites using CRISPR-Cas9-based genome engineering technology. With this method, a reporter sequence of choice can be integrated into a targeted, chosen genomic locus, reflecting clinically relevant integration sites. In the protocol, the design of an HIV-derived reporter and choosing of a target site and gRNA sequence are described. A targeting vector with homology arms is constructed and transfected into Jurkat T cells. The reporter sequence is targeted to the selected genomic site by homologous recombination facilitated by a Cas9-mediated double-strand break at the target site. Single-cell clones are generated and screened for targeting events by flow cytometry and PCR. Selected clones are then expanded, and correct targeting is verified by PCR, sequencing, and Southern blotting. Potential off-target events of CRISPR-Cas9-mediated genome engineering are analyzed. By using this protocol, novel cell culture systems that model HIV infection at clinically relevant integration sites can be generated. Although the generation of single-cell clones and verification of correct reporter sequence integration is time-consuming, the resulting clonal lines are powerful tools to functionally analyze proviral integration site choice.